Skip to main content
Premium Trial:

Request an Annual Quote

LGC Acquires SeraCare Life Sciences, Expands Into Clinical Quality Control Market

NEW YORK (GenomeWeb) – LGC announced today that it has acquired SeraCare Life Sciences, a provider of quality control materials for the infectious disease testing and next-generation sequencing markets.

According to LGC, the acquisition strengthens the firm's position across the clinical quality control tools market and expands its calibration verification materials and proficiency testing offerings.

SeraCare offers tools for diagnosing infectious diseases through its ACCURUN reagents, as well as the NGS markets through its Seraseq brand of products for oncology, NIPT, and inherited disease testing. The firm's global customer base includes in vitro diagnostic assay developers and manufacturers, clinical laboratories, pharmaceutical companies, and proficiency providers.

In addition, LGC noted that the Seraseq clinical genomics tools are complementary to its component offerings to the NGS market, which includes oligonucleotides, molecular biology enzymes, and magnetic beads.

"The team will be a natural fit and addition to our existing calibration verification business," LGC Standards Division Managing Director Euan O'Sullivan said in a statement. "This significant acquisition will also strengthen our presence in the fast-growing molecular diagnostics and NGS reference materials market, complementing our genomics offering."

Financial terms of the agreement were not disclosed.

LGC has acquired a slew of genomic tools companies in the last few years — including Berry and Associates, Bioautomation, Lucigen, and Douglas Scientific — and is now rebranding its genomics divisions as LGC Biosearch Technologies.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.